Continuing Professional Education Credit

SOY CONNECTION Newsletter Vol. 33, No.2
Beyond the Scale: GLP-1 Medications & Weight Maintenance Nutrition Strategies awards 1.0 CPEU in accordance with the Commission on Dietetic Registration’s CPEU Prior Approval Program.

1. GLP-1 RA is an acronym for __________. GLP-1 RA drugs work by binding to a receptor inside a cell or on its surface, mimicking the action of naturally occurring GLP-1.

2. GLP-1 is an ________, which is a hormone released by the gut that helps regulate appetite, blood sugar and digestion.

3. GLP-1 binds to GLP-1 receptors in multiple organs, including the brain, helping to regulate appetite and body weight by promoting satiety, reducing food intake and _________ , leading to a prolonged feeling of fullness.

4. GLP-1 RA medications are a breakthrough for those trying to lose weight because these drugs mimic the action of GLP-1. Research has shown that in addition to weight loss, these drugs may also lower the risk of ________

5. Mary is a 62-year-old woman with type 2 diabetes and cardiovascular risk factors including obesity and hypercholesterolemia. She started semaglutide, a GLP-1 RA drug, 4 months ago and has lost 33 pounds so far, experiencing minimal side effects. However, Mary is feeling physically weaker complaining of weakened muscles. What might be the potential cause of this weakness?

6. Marc, a 55-year-old patient who has been on a GLP-1 RA drug for 1 month, had been experiencing diarrhea initially, now he has constipation. Marc is exercising more and interested in a plant centric diet that provides protein and higher fiber. What suggestions might you provide?

7. Mary is interested in increasing her dietary protein, but she is worried about how doing so might raise her blood lipids and cholesterol even more; Mary’s doctor has told her to limit foods high in saturated fats and simple sugars. Which of the following dietary strategies might you may consider for Mary?

8. Marc returns to your clinic after 6 months of GLP-1 RA treatment and reports he has reached his goal weight. Marc wants to maintain his weight loss and says he has enjoyed adding more soy to his diet. How do soy foods contribute to weight maintenance?

9. Soybean oil carries a Food and Drug Administration qualified health claim which suggests that it may reduce the risk of heart disease by lowering blood cholesterol levels. The claim states, “Supportive but not conclusive scientific evidence suggests that eating about 1½ tablespoons (20.5 grams) daily of soybean oil, which contains ________ fat, may reduce the risk of coronary heart disease.”

10. Although GLP-1 RA drugs have been helpful to patients desiring to lose weight, it is estimated that 50-75% of patients discontinue use after one year, primarily due to cost and unwanted side effects. What are the most common gastrointestinal side effects of these drugs?

11. GLP-1 RAs have been used to treat type 2 diabetes for years and work, in part, by boosting _______secretion after meals, improving blood sugar control, particularly for those with type 2 diabetes.

12. For those patients on GLP-1 RA treatment, long-term success depends on these four interventions, developed, and provided by health professionals to their patients and clients for sustainable weight management.